Beyond erythropoiesis: novel applications for recombinant human erythropoietin.

Abstract

Erythropoietin (EPO) primarily is produced in the kidney and acts as a principal mediator of the physiologic response to hypoxia by increasing red blood cell production. Astrocytes and neurons in the central nervous system (CNS) also are known to produce EPO in response to hypoxia/ischemia. EPO appears to play a neuroprotective role based on preclinical… (More)

Topics

  • Presentations referencing similar topics